Inventor

SAMPATH DEEPAK

US17 patents

⚠️ This page may combine multiple inventors who share the name “SAMPATH DEEPAK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SAMPATH DEEPAK

GENENTECH INC

Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor

Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer

Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor

Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use

Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor

Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor

Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor

Methods and compositions for modulating estrogen receptor mutants

Combinations of AKT inhibitor compounds and erlotinib, and methods of use

Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibitor

Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer

Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use

BELVIN MARCIA

Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use

Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use

NANNINI MICHELLE

Combinations of AKT inhibitor compounds and erlotinib, and methods of use

Combinations of AKT inhibitor compounds and abiraterone, and methods of use

LEE BRIAN

Combinations of AKT and MEK inhibitor compounds, and methods of use